Defining a Differentiated Target Product Profile (TPP) to Win in a Crowded Therapy Area
Background: The client was advancing a Phase II biologic in a chronic inflammatory disease category already dense with competition. While early clinical data showed encouraging efficacy and a managea ...
The Forgotten Power of the TPP: Why Many Biopharma Projects Fail Without It
In the fast‐moving world of biopharma innovation, it’s easy to get excited by the science – the novel target, the breakthrough molecule, the cutting-edge modality. But amid that excitement, one strate ...